Please Wait.....
Report
Latin America Biobanking Market Report and Forecast 2024-2032
Market Report I 2024-06-26 I 140 Pages I EMR Inc.
Latin America Biobanking Market Report and Forecast 2024-2032
Latin America Biobanking Market Size
The global biobanking market was valued at USD 72.1 billion in 2023, with Latin America holding a significant market share. The market is driven by the growing demand for precision medicine and the rising focus on life science research. It is expected to grow at a CAGR of 8.60% during the forecast period of 2024-2032, with the values likely to attain USD 131.1 billion by 2032.
Latin America Biobanking Market Outlook
- Chronic diseases pose a major health challenge in Latin American countries with a substantial economic impact and mortality rates . This rising disease burden is expected to directly impact the market demand.
- One of the major Latin America biobanking market trends is the growing demand for precision medicine which stimulates the need for biobanking services. For instance, Galatea Bio, Inc., is building a biobank to accelerate drug discovery and bring precision medicine to the underserved Latin American population, leveraging advanced sequencing technologies to enrich genomic datasets.
- The growing emphasis on life science research, especially in the field of regenerative medicine and clinical studies, which are heavily dependent on high-quality biological samples is projected to boost the market share.
Latin America Biobanking Market Analysis
A biobank collects and stores biological samples along with associated health data of donors. They serve as a library for researchers and significantly reduce the time and resources needed to conduct a research study. There is a growing emphasis on life science research especially in the field of regenerative medicine and clinical studies which rely heavily on high-quality biological samples and thus are dependent on biobank facilities. This rising demand for well-maintained repositories that can store and manage these samples effectively is expected to drive the Latin America biobanking market growth. Additionally, the increased government initiatives and funding to support the establishment and expansion of biobanks are anticipated to impact the market dynamics.
The rising burden of chronic diseases is projected to impact the market dynamics. Recent data reveals that chronic diseases pose a major health challenge in Latin American countries with a substantial economic impact and mortality rates . Since biobanks act as a prerequisite in the development of new therapeutics and advanced diagnostic techniques, the market demand for these repositories is likely to augment in the forecast period. Moreover, the increasing technological advancements in biobanking practices to enhance research outcomes are anticipated to boost the Latin America biobanking market share.
One of the major market trends is the growing demand for precision medicine which stimulates the need for biobanking services to facilitate personalized approaches to disease treatment and diagnosis. For instance, the Florida-based biotechnology company Galatea Bio, Inc., is building a biobank to accelerate drug discovery and bring precision medicine to the untapped Latin American population. The company plans to have 10 million data points by 2026 and employs Illumina NovaSeq 6000 and NextSeq 2000 Systems to sequence genomes. Thus, the growth in the precision medicine sector is anticipated to elevate the market value in the coming years.
Latin America Biobanking Market Segmentation??
The report offers a detailed analysis of the market based on the following segments:
Market Breakup by Product and Service
Equipment
Consumables
Service
Software
Market Breakup by Application
Regenerative Medicine
Life Science Research
Clinical Research
Market Breakup by Sample Type
Blood Tissue
Nucleic Acids
Cell Lines
Market Breakup by End User
Academic Institutions
Pharma and Biotech Companies
Market Breakup by Country
Brazil
Argentina
Mexico
Others
Leading Players in the Latin America Biobanking Market
The key features of the market report include funding and investment analysis, partnerships, and collaborations analysis by the leading key players. The major companies in the market are as follows:
- Thermo Fisher Scientific, Inc.
- Beckman Coulter, Inc.
- Tecan Trading AG
- PHC Corporation
- Teva Pharmaceutical Industries Ltd.
- BioLife Solutions Inc.
- Merck KGaA
- Taylor-Wharton
- Panasonic Biomedical
- Custom Biogenic Systems
Kindly note that this only represents a partial list of companies, and the complete list has been provided in the report.
FAQs
- What is the Latin America biobanking market forecast outlook for 2024-2032?
The Latin America biobanking market is expected to be driven by the rising demand for the global market, which is anticipated to grow at a CAGR of 6.89% during the forecast period of 2024-2032 and is likely to reach a market value of USD 131.1 billion by 2032.
- What are the major factors aiding the Latin America biobanking market demand?
The growing demand for precision medicine and the rising focus on life science research is fuelling the demand for the market.
- What are the major Latin America biobanking market trends?
One of the significant trends in the market is the growing demand for precision medicine which stimulates the need for biobanking services. Galatea Bio, Inc., is building a biobank to accelerate drug discovery and bring precision medicine to the underserved Latin American population, aiming to collect 10 million data points by 2026.
- What is the market segmentation based on the product and services?
Based on the products and services, the market is segmented into equipment, consumables, services, and software.
- What is the market breakup by sample type?
By sample type, the market is divided into blood tissue, nucleic acids, and cell lines.
- What are the major end users of biobanking?
End users of the market are academic institutions, pharma, and biotech companies.
- What are the applications of biobanking?
Major applications of biobanking include regenerative medicine, life science research, and clinical research.
- What is the market segmentation by countries?
The market segmentation by countries includes Brazil, Argentina, and Mexico, among others.
- Who are the key players involved in the Latin America biobanking market?
The key players in the market are Thermo Fisher Scientific, Inc., Beckman Coulter, Inc., Tecan Trading AG, PHC Corporation, Teva Pharmaceutical Industries Ltd., BioLife Solutions Inc., Merck KGaA, Taylor-Wharton, Panasonic Biomedical, and Custom Biogenic Systems.
Meta description
The Latin America biobanking market is poised for growth, driven by the expansion of the global market, which was valued at USD 72.1 billion in 2023 and is projected to grow at a CAGR of 6.89% during the forecast period of 2024-2032.
1 Preface
1.1 Objectives of the Study
1.2 Key Assumptions
1.3 Report Coverage - Key Segmentation and Scope
1.4 Research Methodology
2 Executive Summary
3 Latin America Biobanking Market Overview
3.1 Latin America Biobanking Market Historical Value (2017-2023)
3.2 Latin America Biobanking Market Forecast Value (2024-2032)
4 Latin America Biobanking Market Landscape*
4.1 Latin America Biobanking: Developers Landscape
4.1.1 Analysis by Year of Establishment
4.1.2 Analysis by Company Size
4.1.3 Analysis by Region
4.2 Latin America Biobanking: Product Landscape
4.2.1 Analysis by Product and Service
4.2.2 Analysis by Application
5 Latin America Biobanking Market Dynamics
5.1 Market Drivers and Constraints
5.2 SWOT Analysis
5.2.1 Strengths
5.2.2 Weaknesses
5.2.3 Opportunities
5.2.4 Threats
5.3 Porter's Five Forces Model
5.3.1 Bargaining Power of Suppliers
5.3.2 Bargaining Power of Buyers
5.3.3 Threat of New Entrants
5.3.4 Threat of Substitutes
5.3.5 Degree of Rivalry
5.4 Key Demand Indicators
5.5 Key Price Indicators
5.6 Industry Events, Initiatives, and Trends
5.7 Value Chain Analysis
6 Latin America Biobanking Market Segmentation (2017-2032)
6.1 Latin America Biobanking Market (2017-2032) by Product and Service
6.1.1 Market Overview
6.1.2 Equipment
6.1.3 Consumables
6.1.4 Service
6.1.5 Software
6.2 Latin America Biobanking Market (2017-2032) by Application
6.2.1 Market Overview
6.2.2 Regenerative Medicine
6.2.3 Life Science Research
6.2.4 Clinical Research
6.3 Latin America Biobanking Market (2017-2032) by Sample Type
6.3.1 Market Overview
6.3.2 Blood Tissue
6.3.3 Nucleic Acids
6.3.4 Cell Lines
6.4 Latin America Biobanking Market (2017-2032) by End User
6.4.1 Market Overview
6.4.2 Academic Institutions
6.4.3 Pharma and Biotech Companies
6.5 Latin America Biobanking Market (2017-2032) by Country
6.5.1 Market Overview
6.5.2 Brazil
6.5.3 Argentina
6.5.4 Mexico
6.5.5 Others
7 Brazil Biobanking Market (2017-2032)
7.1 Brazil Biobanking Market (2017-2032) by Product and Service
7.1.1 Market Overview
7.1.2 Equipment
7.1.3 Consumables
7.1.4 Service
7.1.5 Software
7.2 Brazil Biobanking Market (2017-2032) by Application
7.2.1 Market Overview
7.2.2 Regenerative Medicine
7.2.3 Life Science Research
7.2.4 Clinical Research
7.3 Brazil Biobanking Market (2017-2032) by Sample Type
7.3.1 Market Overview
7.3.2 Blood Tissue
7.3.3 Nucleic Acids
7.3.4 Cell Lines
7.4 Brazil Biobanking Market (2017-2032) by End User
7.4.1 Market Overview
7.4.2 Academic Institutions
7.4.3 Pharma and Biotech Companies
8 Argentina Biobanking Market (2017-2032)
8.1 Argentina Biobanking Market (2017-2032) by Product and Service
8.1.1 Market Overview
8.1.2 Equipment
8.1.3 Consumables
8.1.4 Service
8.1.5 Software
8.2 Argentina Biobanking Market (2017-2032) by Application
8.2.1 Market Overview
8.2.2 Regenerative Medicine
8.2.3 Life Science Research
8.2.4 Clinical Research
8.3 Argentina Biobanking Market (2017-2032) by Sample Type
8.3.1 Market Overview
8.3.2 Blood Tissue
8.3.3 Nucleic Acids
8.3.4 Cell Lines
8.4 Argentina Biobanking Market (2017-2032) by End User
8.4.1 Market Overview
8.4.2 Academic Institutions
8.4.3 Pharma and Biotech Companies
9 Mexico Biobanking Market (2017-2032)
9.1 Mexico Biobanking Market (2017-2032) by Product and Service
9.1.1 Market Overview
9.1.2 Equipment
9.1.3 Consumables
9.1.4 Service
9.1.5 Software
9.2 Mexico Biobanking Market (2017-2032) by Application
9.2.1 Market Overview
9.2.2 Regenerative Medicine
9.2.3 Life Science Research
9.2.4 Clinical Research
9.3 Mexico Biobanking Market (2017-2032) by Sample Type
9.3.1 Market Overview
9.3.2 Blood Tissue
9.3.3 Nucleic Acids
9.3.4 Cell Lines
9.4 Mexico Biobanking Market (2017-2032) by End User
9.4.1 Market Overview
9.4.2 Academic Institutions
9.4.3 Pharma and Biotech Companies
10 Regulatory Framework
11 Funding and Investment Analysis
11.1 Analysis by Funding Instances
11.2 Analysis by Type of Funding
11.3 Analysis by Funding Amount
11.4 Analysis by Leading Players
11.5 Analysis by Leading Investors
11.6 Analysis by Geography
12 Partnership and Collaborations Analysis
12.1 Analysis by Partnership Instances
12.2 Analysis by Type of Partnership
12.3 Analysis by Leading Players
12.4 Analysis by Geography
13 Supplier Landscape
13.1 Market Share by Top 5 Companies
13.2 Thermo Fisher Scientific, Inc.
13.2.1 Financial Analysis
13.2.2 Product Portfolio
13.2.3 Demographic Reach and Achievements
13.2.4 Mergers and Acquisitions
13.2.5 Certifications
13.3 Beckman Coulter, Inc.
13.3.1 Financial Analysis
13.3.2 Product Portfolio
13.3.3 Demographic Reach and Achievements
13.3.4 Mergers and Acquisitions
13.3.5 Certifications
13.4 Tecan Trading AG
13.4.1 Financial Analysis
13.4.2 Product Portfolio
13.4.3 Demographic Reach and Achievements
13.4.4 Mergers and Acquisitions
13.4.5 Certifications
13.5 PHC Corporation
13.5.1 Financial Analysis
13.5.2 Product Portfolio
13.5.3 Demographic Reach and Achievements
13.5.4 Mergers and Acquisitions
13.5.5 Certifications
13.6 Teva Pharmaceutical Industries Ltd.
13.6.1 Financial Analysis
13.6.2 Product Portfolio
13.6.3 Demographic Reach and Achievements
13.6.4 Mergers and Acquisitions
13.6.5 Certifications
13.7 BioLife Solutions Inc.
13.7.1 Financial Analysis
13.7.2 Product Portfolio
13.7.3 Demographic Reach and Achievements
13.7.4 Mergers and Acquisitions
13.7.5 Certifications
13.8 Merck KGaA
13.8.1 Financial Analysis
13.8.2 Product Portfolio
13.8.3 Demographic Reach and Achievements
13.8.4 Mergers and Acquisitions
13.8.5 Certifications
13.9 Taylor- Wharton
13.9.1 Financial Analysis
13.9.2 Product Portfolio
13.9.3 Demographic Reach and Achievements
13.9.4 Mergers and Acquisitions
13.9.5 Certifications
13.10 Panasonic biomedical
13.10.1 Financial Analysis
13.10.2 Product Portfolio
13.10.3 Demographic
13.10.4 Mergers and Acquisitions
13.10.5 Certifications
13.11 Custom biogenic systems
13.11.1 Financial Analysis
13.11.2 Product Portfolio
13.11.3 Demographic Reach and Achievements
13.11.4 Mergers and Acquisitions
13.11.5 Certifications
14 Latin America Biobanking Market - Distribution Model (Additional Insight)
14.1 Overview
14.2 Potential Distributors
14.3 Key Parameters for Distribution Partner Assessment
15 Key Opinion Leaders (KOL) Insights (Additional Insight)
16 Company Competitiveness Analysis (Additional Insight)
16.1 Very Small Companies
16.2 Small Companies
16.3 Mid-Sized Companies
16.4 Large Companies
16.5 Very Large Companies
17 Payment Methods (Additional Insight)
17.1 Government Funded
17.2 Private Insurance
17.3 Out-of-Pocket
*Additional insights provided are customisable as per client requirements.
* The coverage of the Market Landscape section depends on the data availability and may cover a minimum of 80% of the total market. The EMR team strives to make this section as comprehensive as possible.
- Not Sure / Need Reassuring
- Confirm Content
-
Content is provided by our partners and every effort is made to make Market Report details as clear as possible. If you are not sure the exact content you require is included in this study you can Contact us to double check. To do this you can:
Use the ‘? ASK A QUESTION’ below the license / prices and to the right of this box. This will come directly to our team who will work on dealing with your request as soon as possible.
Write to directly on support@scotts-international.com with details. Please include as much information as possible including the name of report or link so our staff will be able to work on you request.
Telephone us directly on 0048 603 394 346 and an experienced member of team will be on hand to answer.
-
- Sample Pages
-
With the vast majority of our partners we can obtain Sample Pages to support your decision. This is something we can arrange without revealing your personal details.
It is important to note that we will not be able to provide you the exact data or statistics such as Market Size and Forecasts. Sample pages usually confirm the layout or the Categories included in Charts and Graphs, excluding specific data.
To ask for Sample Pages by contact us through ‘? ASK A QUESTION’, support@scotts-international.com, or by telephoning 0048 603 394 346.
-
- Check for Alternatives
-
Whilst we try to make our online platform as easy to use as possible there is always the possibility that a better alternative has not been found in your search.
To avoid this possibility Contact us through ‘? ASK A QUESTION’, support@scotts-international.com, or by telephoning 0048 603 394 346 and a Senior Team Member can review your requirements and send a list of possibilities with opinions and recommendations.
-
- Confirm Content
- Prices / Formats / Delivery
- Prices
-
All prices are set by our partners and should be exactly the same as those listed on their own websites. We work on a Revenue share basis ensuring that you never pay more than what is offered elsewhere.
Should you find the price cheaper on another platform we recommend you to Contact us as we should be able to match this price. You can Contact us though through ‘? ASK A QUESTION’, support@scotts-international.com, or by telephoning 0048 603 394 346.
-
- Discounts
-
As we work in close partnership with our Partners from time to time we can secure discounts and assist with negotiations, this is part of our personalised service to you.
Discounts can sometimes be arranged for speedily placed orders; multiple report purchases or Higher License purchases.
To check if a Discount is possible please Contact our experienced team through ‘? ASK A QUESTION’, support@scotts-international.com, or by telephoning 0048 603 394 346.
-
- Available Currencies
-
Most Market Reports on our platform are listed in USD or EURO based on the wishes of our Partners. To avoid currency fluctuations and potential price differentiations we do not offer the possibility to change the currency online.
Should you wish to pay in a different currency to that advertised online we do accept payments in USD, EURO, GBP and PLN. The price will be calculated based on the relevant exchange rate taken from our National Bank.
To pay in a different above currency to that advertised online please Contact our team and a quotation will be sent within a couple of hours with payment details.
-
- Licenses
-
License options vary from Partner to Partner as is usually based on the number of Users that will benefitting from the report. It is very important that License ordered is not breached as this could have potential negative consequences for you individually or your employer.
If you have questions or need confirmation about the specific license we recommend you to Contact us and a detailed explanation will be provided.
-
- Global Site License
-
The Global Site License is the most comprehensive license available. By selecting this license, the Market Report can be shared with other ‘Allowed Users’ and any other member of staff from the same organisation regardless of geographic location.
It is important to note that this may exclude Parent Companies or Subsidiaries.
If you have questions or need confirmation about the specific license we recommend you to Contact us and a detailed explanation will be provided.
-
- Formats
-
The most common format is PDF, however in certain circumstances data may be present in Excel format or Online, especially in the case of Database or Directories. In addition, for certain higher license options a CD may also be provided.
If you have questions or need clarification about the specific formats we recommend you to Contact us and a detailed explanation will be provided.
-
- Delivery
-
Delivery is fulfilled by our partners directly. Once an order has been placed we inform the partner by sharing the delivery email details given in the order process.
Delivery is usually made within 24 hours of an order being placed, however it may take longer should your order be placed prior to the weekend or if otherwise specified on the Market Report details page. Additionally, if details have been not fully completed in the Order process a delay in delivery is possible.
If a delay in delivery is expected you will be informed about it immediately.
-
- Shipping Charges
-
As most Market Reports are delivered in PDF format we almost never have to add additional Shipping Charges. If, however you are ordering a Higher License service or a specific delivery format (e.g. CD version) charges may apply.
If you are concerned about additional Shipping Charges we recommend you to Contact us to double check.
-
- Prices
- Ordering
- By Credit Card
-
We work in Partnership with PayU to ensure payments are made securely in a fast and effortless way. PayU is the e-payments division of Naspers.
Naspers operates in over 133 International Markets and ranks 3rd Globally in terms of the number of e-commerce customers served.
For more information on PayU please visit: https://www.payu.pl/en/about-us
-
- By Money Transfer
-
If you require an invoice prior to payment, this is possible. To ensure a speedy delivery of the Market Report we require all relevant company details and you agree to maximum payment terms of 30 days from receipt of order.
With our regular clients deliver of the Market Report can be made prior to receiving payment, however in some circumstances we may ask for payment to be received before arranging for the Market Report to be delivered.
-
- By Credit Card
- Security
- Website security
-
We have specifically partnered with leading International companies to protect your privacy by using different technologies and processes to ensure security.
Everything submitted to Scotts International is encrypted via SSL (Secure Socket Layer) and all personal information provided to Scotts International is stored on computer systems with limited access in controlled environments.
-
- Credit Card Security
-
We partner with PayU (https://www.payu.pl/en/about-us) to ensure all credit card payments are made securely in a fast and effortless way.
PayU offers 250+ various payment channels and eWallet services across 4 continents allowing buyers to pay electronically, whether on a computer or a mobile device.
-
- Website security